Abstract
Renal artery stenosis (RAS) is most commonly caused by atherosclerotic disease. An alternative common etiology is fibromuscular dysplasia. RAS is present in up to 10% of elderly hypertensive patients, with overall prevalence between 0.5% and 5.5% in patients with chronic kidney disease. Patients with hemodynamically significant RAS have increased cardiovascular morbidity and mortality. Duplex ultrasonography (DUS), magnetic resonance angiography (MRA), computed tomographic angiography (CTA), and invasive angiography have all been used as diagnostic modalities for RAS detection. All patients with RAS should be on intensive medical therapy. Patients with RAS have a hyper reninemic state and despite common beliefs, angiotensin converting enzyme inhibitors (ACEi), and angiotensin receptor blockers (ARBs) are an important part of the therapeutic armamentarium, however they should be managed carefully. High intensity statin is crucial in all patients with atherosclerotic disease. Percutaneous revascularization is reasonable for patients with hemodynamically significant RAS and accelerated hypertension, malignant hypertension, and hypertension refractory to medical therapy. Patient with RAS treated with revascularization and stent placement should have close follow up to monitor their blood pressure, renal function and stent patency with DUS.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Messerli FH, Bangalore S, Makani H, et al. Flash pulmonary edema and bilateral renal artery stenosis: the Pickering syndrome. Eur Heart J. 2011;32:2231–5.
Gray BH, Olin JW, Childs MB, et al. Clinical benefit of renal artery angioplasty with stenting for the control of recurrent and refractory congestive heart failure. Vasc Med. 2002;7:275–9.
Safian RD, Textor SC. Renal-artery stenosis. N Engl J Med. 2001;344(6):431–42.
Mansoor GA. Secondary hypertension: clinical presentation, diagnosis, and treatment. Totowa: Humana Press Inc.; 2004.
Anderson GH Jr, Blakeman N, Streeten DH. The effect of age on prevalence of secondary forms of hypertension in 4429 consecutively referred patients. J Hypertens. 1994;12:609–15.
Lüscher TF, et al. Arterial fibromuscular dysplasia. Mayo Clin Proc. 1987;62(10):931–52.
Birrer M, Do DD, Mahler F, et al. Treatment of renal artery fibromuscular dysplasia with balloon angioplasty: a prospective follow-up study. Eur J Vasc Endovasc Surg. 2002;23:146–52.
Tegtmeyer CJ, Elson J, Glass TA, et al. Percutaneous transluminal angioplasty: the treatment of choice for renovascular hypertension due to fibromuscular dysplasia. Radiology. 1982;143:631–7.
Rimmer JM, Gennari FJ. Atherosclerotic renovascular disease and progressive renal failure. Ann Intern Med. 1993;118:712–9.
Holley KE, Hunt JC, Brown AL Jr, et al. Renal artery stenosis. A clinical-pathologic study in normotensive and hypertensive patients. Am J Med. 1964;37:14–22.
Sawicki PT, Kaiser S, Heinemann L, et al. Prevalence of renal artery stenosis in diabetes mellitus—an autopsy study. J Intern Med. 1991;229:489–92.
Caps MT, Perissinotto C, Zierler RE, et al. Prospective study of atherosclerotic disease progression in the renal artery. Circulation. 1998;98:2866–72.
Hansen KJ, Edwards MS, Craven TE, et al. Prevalence of renovascular disease in the elderly: a population-based study. J Vasc Surg. 2002;36(3):443–5.
Piccoli G, Salomone M, Quarello F, et al. Regional registry of dialysis and transplantation of Piedmont, Italy (RPDT). Thirteen years of experience. Regional Registry of Dialysis and Transplantation. Nephrol Dial Transplant. 1995;10:444–7.
Van Ampting JM, Penne EL, Beek FJ, Koomans H, Boer WH, Beutler JJ. Prevalence of atherosclerotic renal artery stenosis in patients starting dialysis. Nephrol Dial Transplant. 2003;18:1147–51.
Eirin A, Lerman LO. Darkness at the end of the tunnel: poststenotic kidney injury. Physiology (Bethesda). 2013;28:245–53.
Agarwal M, Lynn KL, Richards AM, et al. Hyponatremic-hypertensive syndrome with renal ischemia: an underrecognized disorder. Hypertension. 1999;33:1020–4.
Goldblatt H, Lynch J, Hanzel RF, Summerville WW. Studies on experimental hypertension I: the production of persistent elevation of systolic blood pressure by means of renal ischemia. J Exp Med. 1934;59(3):347–79.
Pickering TG. Renovascular hypertension: etiology and pathophysiology. Semin Nucl Med. 1989;19:79–88.
Textor SC, Lerman L. Renovascular hypertension and ischemic nephropathy. Am J Hypertens. 2010;23:1159–69.
Textor SC. Ischemic nephropathy: where are we now? J Am Soc Nephrol. 2004;15(8):1974–82.
Gloviczki ML, Glockner JF, Lerman LO, et al. Pre-served oxygenation despite reduced blood flow in poststenotic kidneys in human atherosclerotic renal artery stenosis. Hypertension. 2010;55:961–6.
Singh M, Morshedi-Meibodi A, Steen L, Dieter RS. Overlap of atherosclerotic disease. In: Dieter RS, Dieter III R, Dieter Jr R, editors. Peripheral arterial disease. New York: McGraw-Hill Professional; 2009. p. 177–84.
Wollenweber J, Sheps S, Davis G. Clinical course of atherosclerotic renovascular disease. Am J Cardiol. 1968;21(1):60–71.
Conlon PJ, Little MA, Pieper K, et al. Severity of renal vascular disease predicts mortality in patients undergoing coronary angiography. Kidney Int. 2001;60:1490–7.
Valentine R, Clagett G, Miller G, Myers S, Martin J, Chervu A. The coronary risk of unsuspected renal artery stenosis. J Vasc Surg. 1993;18(3):433–9, discussion 439–440.
Kuroda S, Nishida N, Uzu T, et al. Prevalence of renal artery stenosis in autopsy patients with stroke. Stroke. 2000;31(1):61–5.
Conlon PJ, Athirakul K, Kovalik E, et al. Survival in renal vascular disease. J Am Soc Nephrol. 1998;9:252–6.
Mui KW, Sleeswijk M, van den Hout H, et al. Incidental renal artery stenosis is an independent predictor of mortality in patients with peripheral vascular disease. J Am Soc Nephrol. 2006;17:2069–74.
Rossi G, Rossi A, Zanin L, et al. Excess prevalence of extracranial carotid artery lesions in renovascular hypertension. Am J Hypertension. 1992;5(1):8–15.
Khosla S, White CJ, Collins TJ, Jenkins JS, Shaw D, Ramee SR. Effects of renal artery stent implantation in patients with renovascular hypertension presenting with unstable angina or congestive heart failure. Am J Cardiol. 1997;80(3):363–6.
Calhoun DA, Jones D, Textor S, Goff DC, Murphy TP, Toto RD, et al. Resistant hypertension: diagnosis, evaluation, and treatment: a scientific statement from the American Heart Association Professional Education Committee of the Council for High Blood Pressure Research. Hypertension. 2008;51:1403–19.
Jacobson HR. Ischemic renal disease: an overlooked clinical entity? Kidney Int. 1988;34:729–43.
Breyer JA, Jacobson HR. Ischemic nepropathy. Curr Opin Nephrol Hypertens. 1993;2:216–24.
Preston RA, Epstein M. Ischemic renal disease: an emerging cause of chronic renal failure and end-stage renal disease. J Hypertension. 1997;15:1365–77.
Baboola K, Evans C, Moore RH. Incidence of end-stage renal disease in medically treated patients with severe bilateral atherosclerotic renovascular disease. Am J Kidney Dis. 1998;31:971–7.
Taylor DC, Kettler MD, Moneta GL, et al. Duplex ultrasound scanning in the diagnosis of renal artery stenosis: a prospective evaluation. J Vasc Surg. 1988;7:363–9.
Dieter R, Schmidt W, Pacanowski J, Jaff MR. Renovascular hypertension. Expert Rev Cardiovasc Ther. 2005;3(3):413–22.
Hansen KJ, Tribble RW, Reavis SW, et al. Renal duplex sonography: evaluation of clinical utility. J Vasc Surg. 1990;12(3):227–36.
Kawashima A, Sandler CM, Ernst RD, et al. CT evaluation of renovascular disease. Radiographics. 2000;20:1321–40.
Kim TS, Chung JW, Park JH, et al. Renal artery evaluation: comparison of spiral CT angiography to intra-arterial DSA. J Vasc Interv Radiol. 1998;9:553–9.
Tafur-Soto JD, White CJ. Renal artery stenosis. Cardiol Clin. 2015;33:59–73.
Wittenberg G, Kenn W, Tschammler A, Sandstede J, Hahn D. Spiral CT angiography of renal arteries: comparison with angiography. Eur Radiol. 1999;9(3):546–51.
Galanski M, Prokop M, Chavan A, Schaefer C, Jandeleit K, Olbricht C. [Accuracy of CT angiography in the diagnosis of renal artery stenosis]. Rofo. 1994;161(6):519–25. German.
McCullough PA, Adam A, Becker CR, et al. Risk prediction of contrast-induced nephropathy. Am J Cardiol. 2006;98:27K–36K.
McCullough PA, Adam A, Becker CR, et al. Epidemiology and prognostic implications of contrast-induced nephropathy. Am J Cardiol. 2006;98:5K–13K.
Turgutalp K, Kiykim A, Ozhan O, et al. Comparison of diagnostic accuracy of Doppler USG and contrast-enhanced magnetic resonance angiography and selective renal arteriography in patients with atherosclerotic renal artery stenosis. Med Sci Monit. 2013;19:475–82.
Tan KT, van Beek EJ, Brown PW, et al. Magnetic resonance angiography for the diagnosis of renal artery stenosis: a meta-analysis. Clin Radiol. 2002;57:617–24.
Hirsch AT, Haskal ZJ, Hertzer NR, Bakal CW, Creager MA, Halperin JL, et al. ACC/AHA guidelines for the management of patients with peripheral arterial disease (lower extremity, renal, mesenteric, and abdominal aortic). J Vasc Interv Radiol. 2006;17:1383–98.
Lao D, Parasher PS, Cho KC, Yeghiazarians Y. Atherosclerotic renal artery stenosis—diagnosis and treatment. Mayo Clin Proc. 2011;86:649–57.
Cooper CJ, Murphy TP, Cutlip DE, et al. Stenting and medical therapy for atherosclerotic renal-artery stenosis. N Engl J Med. 2014;370:13–22.
Chrysochou C, Foley RN, Young JF, et al. Dispelling the myth: the use of renin-angiotensin blockade in atheromatous renovascular disease. Nephrol Dial Transplant. 2012;27:1403–9.
Hackam DG, Duong-Hua ML, Mamdani M, et al. Angiotensin inhibition in renovascular disease: a population-based cohort study. Am Heart J. 2008;156:549–55.
Dieter R, Weber B. Renal artery stenosis: epidemiology and treatment. Int J Nephrol Renovasc Dis. 2014;7:169–81.
Bates MC, Campbell JE, Stone PA, Jaff MR, Broce M, Lavigne PS. Factors affecting long-term survival following renal artery stenting. Catheter Cardiovasc Interv. 2007;69:1037–43.
Blum U, Krumme B, Flügel P, et al. Treatment of ostial renal-artery stenoses with vascular endoprostheses after unsuccessful balloon angioplasty. N Engl J Med. 1997;336:459–65.
Benjamin MM, Fazel P, Filardo G, et al. Prevalence of and risk factors of renal artery stenosis in patients with resistant hypertension. Am J Cardiol. 2014;113:687–90.
Kapoor N, Fahsah I, Karim R, et al. Physiological assessment of renal artery stenosis: comparisons of resting with hyperemic renal pressure measurements. Catheter Cardiovasc Interv. 2010;76:726–32.
Modrall JG, Rosero EB, Smith ST, et al. Operative mortality for renal artery by-pass in the United States: results from the National Inpatient Sample. J Vasc Surg. 2008;48:317–22.
Weibull H, Bergqvist D, Bergentz SE, Jonsson K, Hulthén L, Manhem P. Percutaneous transluminal renal angioplasty versus surgical reconstruction of atherosclerotic renal artery stenosis: a prospective randomized study. J Vasc Surg. 1993;18(5):841–50; discussion 850–852.
Van de ven PJG, Kaatee R, Beurtler JJ, et al. Arterial stenting and balloon angioplasty in ostial atherosclerotic renovascular disease: a randomised trial. Lancet 1999;353(9149):282–6.
Subramanian R, White CJ, Rosenfield K, et al. Renal fractional flow reserve: a hemodynamic evaluation of moderate renal artery stenosis. Catheter Cardiovasc Interv. 2005;64:480–6.
De Bruyne B, Manoharan G, Pijls NH, et al. Assessment of renal artery stenosis severity by pressure gradient measurements. J Am Coll Cardiol. 2006;48:1851–5.
Bax L, Woittiez AJ, Kouwenberg HJ, et al. Stent placement in patients with atherosclerotic renal artery stenosis and impaired renal function: a randomized trial. Ann Intern Med. 2009;150(12):840–1. W150.
White CJ. Kiss my astral: one seriously flawed study of renal stenting after another. Catheter Cardiovasc Interv. 2010;75(2):305–7.
van Jaarsveld BC, Krijnen P, Pieterman H, et al. The effect of balloon angioplasty on hypertension in atherosclerotic renal-artery stenosis. Dutch Renal Artery Stenosis Intervention Cooperative Study Group. N Engl J Med. 2000;342(14):1007–14.
Wheatley K, Ives N, Gray R, et al. ASTRAL investigators revascularization versus medical therapy for renal-artery stenosis. N Engl J Med. 2009;361(20):1953–62.
Cooper CJ, Murphy TP, Cutlip DE, et al. CORAL investigators stenting and medical therapy for atherosclerotic renal-artery stenosis. N Engl J Med. 2014;370(1):13–22.
Anderson JL, Halperin JL, Albert NM, Bozkurt B, Brindis RG, Curtis LH, et al. Management of patients with peripheral artery disease (compilation of 2005 and 2011 ACCF/AHA guideline recommendations): a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Circulation. 2013;127(13):1425–43.
Aboyans V, et al; ESC Scientific Document Group. 2017 ESC guidelines on the diagnosis and treatment of peripheral arterial diseases, in collaboration with the European Society for Vascular Surgery (ESVS): document covering atherosclerotic disease of extracranial carotid and vertebral, mesenteric, renal, upper and lower extremity arteries endorsed by: the European Stroke Organization (ESO) The Task Force for the Diagnosis and Treatment of Peripheral Arterial Diseases of the European Society of Cardiology (ESC) and of the European Society for V... Eur Heart J. 2017;32(22):2851–906.
Parikh SA, Shishehbor MH, Gray BH, White CJ, Jaff MR. SCAI expert consensus statement for renal artery stenting appropriate use. Catheter Cardiovasc Interv. 2014;84(7):1163–71.
Pizzolo F, Mansueto G, Minniti S, et al. Renovascular disease: effect of ACE gene deletion polymorphism and endovascular revascularization. J Vasc Surg. 2004;39:140–7.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2021 Springer Nature Switzerland AG
About this chapter
Cite this chapter
Hasan, M., Tafur-Soto, J., Ventura, H. (2021). Cardiac Consequences of Renal Artery Stenosis. In: McCullough, P.A., Ronco, C. (eds) Textbook of Cardiorenal Medicine. Springer, Cham. https://doi.org/10.1007/978-3-030-57460-4_20
Download citation
DOI: https://doi.org/10.1007/978-3-030-57460-4_20
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-57459-8
Online ISBN: 978-3-030-57460-4
eBook Packages: MedicineMedicine (R0)